Mesenchymal Stem Cells Early Response to Low-Dose Ionizing Radiation. 2020

Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
Department of Molecular Biology, Research Centre for Medical Genetics, Moscow, Russia.

BACKGROUND Mesenchymal stem cells (MSCs) are applied as the therapeutic agents, e.g., in the tumor radiation therapy. OBJECTIVE To evaluate the human adipose MSC early response to low-dose ionizing radiation (LDIR). METHODS We investigated different LDIR (3, 10, and 50 cGy) effects on reactive oxygen species production, DNA oxidation (marker 8-oxodG), and DNA breaks (marker ɣ H2AX) in the two lines of human adipose MSC. Using reverse transcriptase-polymerase chain reaction, fluorescence-activated cell sorting, and fluorescence microscopy, we determined expression of genes involved in the oxidative stress development (NOX4), antioxidative response (NRF2), antiapoptotic and proapoptotic response (BCL2, BCL2A1, BCL2L1, BIRC2, BIRC3, and BAX1), in the development of the nuclear DNA damage response (DDR) (BRCA1, BRCA2, ATM, and P53). Cell cycle changes were investigated by genes transcription changes (CCND1, CDKN2A, and CDKN1A) and using proliferation markers KI-67 and proliferating cell nuclear antigen (PCNA). RESULTS Fifteen to 120 min after exposure to LDIR in MSCs, transient oxidative stress and apoptosis of the most damaged cells against the background of the cell cycle arrest were induced. Simultaneously, DDR and an antiapoptotic response were found in other cells of the population. The 10-cGy dose causes the strongest and fastest DDR following cell nuclei DNA damage. The 3-cGy dose induces a less noticeable and prolonged response. The maximal low range dose, 50 cGy, causes a damaging effect on the MSCs. CONCLUSIONS Transient oxidative stress and the death of a small fraction of the damaged cells are essential components of the MSC population response to LDIR along with the development of DDR and antiapoptotic response. A scheme describing the early MSC response to LDIR is proposed.

UI MeSH Term Description Entries

Related Publications

Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
March 2016, Cytotherapy,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
August 2017, Tissue engineering and regenerative medicine,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
January 2014, Mutation research. Reviews in mutation research,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
September 2006, International journal of radiation oncology, biology, physics,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
December 2012, Dose-response : a publication of International Hormesis Society,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
January 2018, Journal of neurosurgery,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
January 2017, Oxidative medicine and cellular longevity,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
July 2012, Molecular bioSystems,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
January 2001, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Marina Konkova, and Margarita Abramova, and Andrey Kalianov, and Elizaveta Ershova, and Olga Dolgikh, and Pavel Umriukhin, and Vera Izhevskaya, and Sergey Kutsev, and Natalia Veiko, and Svetlana Kostyuk
December 2013, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!